Hodgkin Disease [clinicaltrials_resource:1d836c68c4cdb16b25ba4d0e6c1d8f4d]
clinicaltrials:NCT00025662Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma [clinicaltrials:NCT00026208]Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy [clinicaltrials:NCT00038558]Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer [clinicaltrials:NCT00039676]Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [clinicaltrials:NCT00039910]A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [clinicaltrials:NCT00051597]clinicaltrials:NCT00058773clinicaltrials:NCT00062868Study of TPI 287 in Patients With Advanced Malignancies [clinicaltrials:NCT00113724]Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies [clinicaltrials:NCT00145613]Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma [clinicaltrials:NCT00148018]High Dose Chemotherapy Followed By PBSC Rescue for HD [clinicaltrials:NCT00186251]Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET [clinicaltrials:NCT00188149]Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training [clinicaltrials:NCT00196885]clinicaltrials:NCT00225173clinicaltrials:NCT00241358A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [clinicaltrials:NCT00261677]clinicaltrials:NCT00275262Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease [clinicaltrials:NCT00388349]clinicaltrials:NCT00393380clinicaltrials:NCT00398411clinicaltrials:NCT00444912Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00478959]Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies [clinicaltrials:NCT00514722]Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00534820]Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT [clinicaltrials:NCT00534989]Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases [clinicaltrials:NCT00538551]clinicaltrials:NCT00540007Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [clinicaltrials:NCT00562224]A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00636311]clinicaltrials:NCT00724984clinicaltrials:NCT00733824A Phase 1 Dose-escalation Study of a Cell Cycle Inhibitor With and Without Gemcitabine in Patients With Solid Tumors or Lymphoma (Study P05248) [clinicaltrials:NCT00779584]clinicaltrials:NCT00871702Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma [clinicaltrials:NCT00901069]Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma [clinicaltrials:NCT00903890]Pilot Study of Unrelated Cord Blood Transplantation [clinicaltrials:NCT00916045]clinicaltrials:NCT01018979Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy [clinicaltrials:NCT01078350]clinicaltrials:NCT01121120
condition [clinicaltrials_vocabulary:condition]
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [clinicaltrials:NCT00000626]A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [clinicaltrials:NCT00001430]clinicaltrials:NCT00001575Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002461]Radiation Therapy or No Radiation Therapy Following Chemotherapy in Treating Patients With Stage III or Stage IV Hodgkin's Disease [clinicaltrials:NCT00002462]clinicaltrials:NCT00002495Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00002522]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]clinicaltrials:NCT00002561SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease [clinicaltrials:NCT00002563]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease [clinicaltrials:NCT00002714]Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma [clinicaltrials:NCT00002715]clinicaltrials:NCT00002745clinicaltrials:NCT00002827Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease [clinicaltrials:NCT00002987]clinicaltrials:NCT00003114Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003210]Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection [clinicaltrials:NCT00003262]Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00003389]Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease [clinicaltrials:NCT00003421]Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [clinicaltrials:NCT00003631]Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma [clinicaltrials:NCT00003741]Rituximab in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00003820]clinicaltrials:NCT00003849Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003924]Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [clinicaltrials:NCT00003936]Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00003970]clinicaltrials:NCT00004010Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease [clinicaltrials:NCT00004169]Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004171]17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [clinicaltrials:NCT00004241]Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004908]clinicaltrials:NCT00005090clinicaltrials:NCT00005578Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00005584]Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease [clinicaltrials:NCT00005595]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment [clinicaltrials:NCT00005811]
condition browse [clinicaltrials_vocabulary:condition-browse]
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [clinicaltrials:NCT00000626]A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [clinicaltrials:NCT00001430]clinicaltrials:NCT00001575Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002461]Radiation Therapy or No Radiation Therapy Following Chemotherapy in Treating Patients With Stage III or Stage IV Hodgkin's Disease [clinicaltrials:NCT00002462]clinicaltrials:NCT00002495Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [clinicaltrials:NCT00002522]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]clinicaltrials:NCT00002561SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease [clinicaltrials:NCT00002563]Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease [clinicaltrials:NCT00002714]Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma [clinicaltrials:NCT00002715]clinicaltrials:NCT00002745clinicaltrials:NCT00002827Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease [clinicaltrials:NCT00002987]clinicaltrials:NCT00003114Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003210]Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection [clinicaltrials:NCT00003262]Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00003389]Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease [clinicaltrials:NCT00003421]Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [clinicaltrials:NCT00003631]Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma [clinicaltrials:NCT00003741]Rituximab in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00003820]clinicaltrials:NCT00003849Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003924]Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [clinicaltrials:NCT00003936]Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00003970]clinicaltrials:NCT00004010Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease [clinicaltrials:NCT00004169]Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004171]17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [clinicaltrials:NCT00004241]Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00004908]clinicaltrials:NCT00005090clinicaltrials:NCT00005578Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [clinicaltrials:NCT00005584]Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease [clinicaltrials:NCT00005595]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment [clinicaltrials:NCT00005811]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Hodgkin Disease [clinicaltrials_resource:1d836c68c4cdb16b25ba4d0e6c1d8f4d]
Bio2RDF identifier
1d836c68c4cdb16b25ba4d0e6c1d8f4d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1d836c68c4cdb16b25ba4d0e6c1d8f4d
identifier
clinicaltrials_resource:1d836c68c4cdb16b25ba4d0e6c1d8f4d
title
Hodgkin Disease
@en
type
label
Hodgkin Disease [clinicaltrials_resource:1d836c68c4cdb16b25ba4d0e6c1d8f4d]
@en
Hodgkin Disease